GoalVest Advisory LLC cut its position in shares of Eli Lilly and Company (NYSE:LLY – Free Report) by 32.1% in the second quarter, Holdings Channel reports. GoalVest Advisory LLC’s holdings in Eli Lilly and Company were worth $2,611,000 as of its most recent SEC filing. Key Stories Impacting Eli Lilly and CompanyHere are the key news stories impacting Eli Lilly and Company this week:Positive Sentiment: Beat-and-raise quarter reinforces growth outlook. Eli Lilly and Company Profile(Free Report)Eli Lilly and Company (NYSE: LLY) is a global pharmaceutical company founded in 1876 and headquartered in Indianapolis, Indiana. Receive News & Ratings for Eli Lilly and Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eli Lilly and Company and related companies with MarketBeat.com's FREE daily email newsletter.